Sernova Corp., a regenerative medicine company, engages in the development and commercializing of its proprietary Cell Pouch and associated technologies. The company's proprietary Cell Pouch and associated technologies include therapeutic cells and local immune protection. It focuses on developing medical devices and combination products for patients with chronic metabolic, neurological, and haematological diseases. The company's Cell Pouch System is a device for the placement of therapeutic cells which becomes an organ-like structure with microvessels for the nutrition and protection of cells. It is also developing Sertolin, an immune protection technology that protects therapeutic cell types, such as insulin producing islets from immune system attack within the Cell Pouch. Sernova Corp. is based in London, Canada.